Skip to content
10-Q

Quarterly Report

XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

0001213900-19-023569

← back to feed
Filed
Nov 14, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 8, 2019 46.27M sh
Capex Q3 2019 · Sep 30, 2019 $33.77K
Capex Q3 2019 · Sep 30, 2018 $2.44K
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$9.17M
Operating Cash Flow restated Q3 2019 · Sep 30, 2018 −$6.66M
Short Term Debt Q3 2019 · Sep 30, 2019 $49.47K
Cash And Equivalents Q3 2019 · Sep 30, 2019 $27.23K
Cash And Equivalents Q3 2019 · Dec 31, 2018 $4.75M
Cash And Equivalents restated Q3 2019 · Sep 30, 2018 $12.11M
Cash And Equivalents restated Q3 2019 · Dec 31, 2017 $100.34K
Stockholders Equity Q3 2019 · Sep 30, 2019 −$19.85M
Stockholders Equity Q3 2019 · Jun 30, 2019 −$15.04M
Stockholders Equity Q3 2019 · Dec 31, 2018 −$20.09M
Stockholders Equity restated Q3 2019 · Sep 30, 2018 $2.47M
Stockholders Equity Q3 2019 · Jun 30, 2018 −$11.26M
Stockholders Equity restated Q3 2019 · Dec 31, 2017 −$5.73M
Current Liabilities Q3 2019 · Sep 30, 2019 $20.59M
Current Liabilities Q3 2019 · Dec 31, 2018 $17.65M
Total Liabilities Q3 2019 · Sep 30, 2019 $20.59M
Total Liabilities Q3 2019 · Dec 31, 2018 $17.65M
Current Assets Q3 2019 · Sep 30, 2019 $232.87K
Current Assets Q3 2019 · Dec 31, 2018 $5.02M
Total Assets Q3 2019 · Sep 30, 2019 $738.8K
Total Assets Q3 2019 · Dec 31, 2018 $5.46M
Sga Expense Q3 2019 · Sep 30, 2019 $1.13M
Sga Expense Q3 2019 · Sep 30, 2019 $11.35M
Sga Expense Q3 2019 · Sep 30, 2018 $608.26K
Sga Expense Q3 2019 · Sep 30, 2018 $1.46M
Rd Expense Q3 2019 · Sep 30, 2019 $3.83M
Rd Expense Q3 2019 · Sep 30, 2019 $10.72M
Rd Expense Q3 2019 · Sep 30, 2018 $1.68M
Rd Expense Q3 2019 · Sep 30, 2018 $6.02M
Net Income Q3 2019 · Sep 30, 2019 −$4.98M
Net Income Q3 2019 · Sep 30, 2019 −$22.17M
Net Income Q3 2019 · Jun 30, 2019 −$17.2M
Net Income restated Q3 2019 · Sep 30, 2018 −$2.41M
Net Income restated Q3 2019 · Sep 30, 2018 −$7.74M
Net Income Q3 2019 · Jun 30, 2018 −$5.33M
Operating Income Q3 2019 · Sep 30, 2019 −$4.96M
Operating Income Q3 2019 · Sep 30, 2019 −$22.12M
Operating Income restated Q3 2019 · Sep 30, 2018 −$2.41M
Operating Income restated Q3 2019 · Sep 30, 2018 −$7.75M